Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. EDIT will report Complete Editas Medicine Inc. stock information by Barron's. View real-time EDIT stock price and news, along with industry-best analysis. Get Editas Medicine Inc (EDIT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Based on short-term price targets offered by 13 analysts, the average price target for Editas Medicine comes to $ The forecasts range from a low of $ The average price target is $ with a high estimate of $18 and a low estimate of $7. Sign in to your SmartPortfolio to see more analyst recommendations.
Complete Editas Medicine Inc. stock information by Barron's. View real-time EDIT stock price and news, along with industry-best analysis. The latest Editas Medicine stock prices, stock quotes, news, and EDIT history to help you invest and trade smarter. View Editas Medicine, Inc. EDIT stock quote prices, financial information, real-time forecasts, and company news from CNN. Based on 12 Wall Street analysts offering 12 month price targets for Editas Medicine in the last 3 months. The average price target is € with a high. Find the latest Editas Medicine Inc (EDIT) stock forecast, month price target, predictions and analyst recommendations. EDIT | Complete Editas Medicine Inc. stock news by MarketWatch. View real Editas Medicine stock price target cut to $35 from $80 at Truist. Nov. The 10 analysts with month price forecasts for Editas Medicine stock have an average target of , with a low estimate of and a high estimate of Track Editas Medicine Inc (EDIT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an. Editas Medicine, Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple. EDIT / Editas Medicine, Inc. (NasdaqGS) - Forecast, Price Target, Estimates, Predictions ; Projected Stock Price. $ ↑%. Estimated share price by.
The current price of EDIT is USD — it has increased by % in the past 24 hours. Watch Editas Medicine, Inc. stock price performance more closely on the. Find the latest Editas Medicine, Inc. (EDIT) stock quote, history, news and other vital information to help you with your stock trading and investing. Based on the average yearly growth of the Editas Medicine stock in the last 10 years, the EDIT stock forecast for the beginning of next year is $ Analysts average stock forecasts to be materialized ratio is % with an average time for these price targets to be met of days. Highest price target. The forecasts for Editas Medicine, Inc. (EDIT) range from a low of $7 to a high of $ The average price target represents a increase of $ from the last. The Editas Medicine stock price may drop from USD to USD. The change will be %. Will EDIT stock price grow / rise / go up? No. See above. According to the 10 analysts' twelve-month price targets for Editas Medicine, the average price target is $ The highest price target for EDIT is $ 1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $ Is It a Buy Around $5? The company has great potential if and when it enters the commercial. Editas Medicine (EDIT) stock price prediction is 0 USD. The Editas Medicine stock forecast is 0 USD for September 06, Saturday with technical analysis.
Editas Medicine Stock (NASDAQ: EDIT) stock price, news, charts, stock research, profile. According to analysts, EDIT price target is USD with a max estimate of USD and a min estimate of USD. The average stock forecast for Editas Medicine Inc (EDIT) is USD. This price target corresponds to an upside of %. The range of stock forecasts. A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. See Editas Medicine, Inc. (EDIT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades Analyst Price Targets.
Editas Medicine is forecast to grow earnings and revenue by % and % per annum respectively. EPS is expected to grow by % per annum. Return on equity. Editas Medicine (EDIT) Stock Price Forecast: AI Forecasts EDIT Stock Price To Be Around $ In A Month (Up 26%). AI EDIT Forecast · 1. Positive trial updates (30% chance) could lift prices toward $ · 2. Market skepticism continues (50% chance), keeping prices around $ Editas Medicine Inc Stock Price Forecast, "EDIT" Predictons for Based on the Editas Medicine Inc stock forecast from 6 analysts, the average analyst target price for Editas Medicine Inc is USD over the next 12 months. Editas Medicine stock price forecast: $7; Market Cap: M, Enterprise value: M, P/E: , PEG ratio: , EPS: , Revenue: M. Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.
Best Coding Language For Blockchain | How To Make Money From Watching Videos Online